Rates of hospitalization and in-hospital mortality dropped significantly for people with idiopathic pulmonary fibrosis (IPF) in the…
Articles by Steve Bryson, PhD
Treating acute exacerbations with the protein thrombomodulin (ART-123) in idiopathic pulmonary fibrosis (IPF) patients may be associated…
Low levels of a protein called esRAGE, present in the blood and lungs of people with…
Survival chances for people with an acute exacerbation linked to idiopathic pulmonary fibrosis (IPF)…
Ofev, an approved treatment of idiopathic pulmonary fibrosis (IPF), may…
Chronic lung infections caused by a variety of bacteria are a serious complication in people with idiopathic pulmonary…
Stimulating the aryl hydrocarbon receptor (AhR), found across the immune system, via a naturally produced chemical…
A large-scale analysis of multiple genome-wide studies has identified three new gene variants — mutations in…
A decline in back muscle mass is linked to poor clinical outcomes in patients with idiopathic pulmonary…
A high number of bacteria in the lungs of people with idiopathic pulmonary fibrosis (IPF) is linked to disease…